搜索
Affimed NV
AFMD添加自选
0.181USD
0.0000.00%
收盘 06/30, 16:00（美东）报价延迟15分钟
2.98M总市值
亏损市盈率 TTM
关于 Affimed NV 公司
Affimed NV 是一家临床阶段的生物制药公司，专注于发现和开发癌症免疫疗法。该公司的候选产品是在免疫肿瘤学领域开发的，免疫肿瘤学代表了一种癌症研究方法，旨在利用人体自身的免疫系统对抗肿瘤细胞。其产品线包括 AFM13、AFM13 + 过继性 NK 细胞、AFM13 + 抗 PD-1、AMF24、AMF26、AMF28 和 AMF32。该公司正在招募患者参加 AFM13 的注册导向研究，用于治疗 CD30 阳性复发/难治性外周 T 细胞淋巴瘤，以及 AFM24 的 1/2a 期剂量递增/扩展研究，用于治疗晚期 EGFR 表达实体瘤。其临床前候选产品包括用于治疗多发性骨髓瘤的 AMF26，以及用于治疗多种肿瘤靶点的 AMF28 和 AMF32。此外，该公司还与 Genentech 合作开发和商业化用于治疗多种癌症的某些候选产品。
Affimed NV简介
公司代码AFMD
公司名称Affimed NV
上市日期Sep 12, 2014
CEOMr. Shawn M. Leland
员工数量76
证券类型Ordinary Share
年结日Sep 12
公司地址Im Neuenheimer Feld 582
城市HEIDELBERG
上市交易所Berne Stock Exchange
国家Germany
邮编69120
电话49621560030
网址https://www.affimed.com/
公司代码AFMD
上市日期Sep 12, 2014
CEOMr. Shawn M. Leland
Affimed NV公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Wolfgang Fischer, Ph.D.
Dr. Wolfgang Fischer, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
145.54K
+0.02%
Ms. Denise Mueller
Ms. Denise Mueller
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
89.88K
+0.07%
Dr. Andreas Harstrick, M.D.
Dr. Andreas Harstrick, M.D.
Chief Medical Officer, Member of the Management Board
Chief Medical Officer, Member of the Management Board
76.04K
+0.12%
Dr. Mathieu Simon
Dr. Mathieu Simon
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.00K
+0.24%
Mr. Harry Welten
Mr. Harry Welten
Consulting Chief Financial Officer, Member of the Management Board
Consulting Chief Financial Officer, Member of the Management Board
15.00K
+0.24%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
14.00K
+0.12%
Ms. Uta Kemmerich-Keil
Ms. Uta Kemmerich-Keil
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
11.00K
+0.76%
Mr. Shawn M. Leland
Mr. Shawn M. Leland
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Bernhard R. M. Ehmer
Dr. Bernhard R. M. Ehmer
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Thomas Hecht, M.D.
Dr. Thomas Hecht, M.D.
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Wolfgang Fischer, Ph.D.
Dr. Wolfgang Fischer, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
145.54K
+0.02%
Ms. Denise Mueller
Ms. Denise Mueller
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
Chief Business Officer and Co-President Affimed Inc, Member of the Management Board
89.88K
+0.07%
Dr. Andreas Harstrick, M.D.
Dr. Andreas Harstrick, M.D.
Chief Medical Officer, Member of the Management Board
Chief Medical Officer, Member of the Management Board
76.04K
+0.12%
Dr. Mathieu Simon
Dr. Mathieu Simon
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.00K
+0.24%
Mr. Harry Welten
Mr. Harry Welten
Consulting Chief Financial Officer, Member of the Management Board
Consulting Chief Financial Officer, Member of the Management Board
15.00K
+0.24%
Dr. Annalisa M. Jenkins
Dr. Annalisa M. Jenkins
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
14.00K
+0.12%
常见问题
Affimed NV的前五大股东是谁？
Affimed NV 的前五大股东如下：Dr. Wolfgang Fischer, Ph.D.
有多少机构持有Affimed NV(AFMD)的股份？
截至2026Q1，共有73家机构持有Affimed NV的股份，合计持有的股份价值约为1.13K，占公司总股份的0.01%。与2025Q4相比，机构持股有所增加，增幅为-5189114.00。
